ORIGINAL RESEARCH article
Front. Nutr.
Sec. Clinical Nutrition
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1639068
This article is part of the Research TopicNutrition, Inflammation and Oxidative Stress in Obstetrics and GynecologyView all 19 articles
The associations of Maternal Serum Ferritin Levels with Hypertensive Disorders of Pregnancy: A Longitudinal Cohort Study
Provisionally accepted
- 1Seventh People's Hospital of Shanghai, Shanghai, China
- 2Tongji University School of Medicine, Shanghai, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background The longitudinal fluctuations in maternal serum ferritin (SF) levels during gestation, acting as indirect indicators of iron supplementation, have not been thoroughly investigated in relation to the incidence of hypertensive disorders of pregnancy (HDP). Methods A retrospective cohort investigation was carried out at a tertiary maternity hospital in Shanghai, involving women with serum ferritin (SF) measurements at 8.0-13.6 gestational weeks(GW) and at 29.0-31.6 GW. Logistic regression analysis was employed to evaluate the relationship between maternal SF levels, their longitudinal variations, with the risk of HDP. Results The study included 17 472 women, among whom 473(2.71%) developed gestational hypertension (GH) and 560(3.21%) developed preeclampsia (PE). Adjusted odds ratios (ORs) (95% confidence intervals 1 )for HDP across ascending quartiles of SF concentrations were as follows: at 8.0-13.6 GW, 1.00 (reference), 1.043 (0.864-1.258), 1.060 (0.878-1.279), and 1.234 (1.027-1.482); and at 29.0-31.6 GW, 1.00 (reference), 0.973 (0.800-1.181), 1.076 (0.890-1.301), and 1.299 (1.082-1.560). Women with SF levels in the highest quartile at 8.0-13.6 GW exhibited reduced HDP risk when their SF levels declined to the lowest quartile by 29.0-31.6 GW. Conversely, those with SF levels in the lowest quartile early in pregnancy but transitioning to the highest quartile later in pregnancy demonstrated a significantly elevated HDP incidence (8.2%; OR: 1.445, 95% CI: 1.003-2.081). Conclusions Maternal SF levels demonstrated an independent positive association with HDP risk during early and late gestational stages. These findings suggest that routine iron supplementation in iron-replete women may exacerbate HDP risk and warrants careful reconsideration.
Keywords: Hypertensive disorders of pregnancy, iron supplementation, longitudinal changes, Pregnant Women, Serum ferritin
Received: 01 Jun 2025; Accepted: 20 Oct 2025.
Copyright: © 2025 Mo, Wang, Qu and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Cuicui Qu, 413531243@qq.com
Xiaohua Liu, annaabcd114@hotmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.